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Background
Osteoporosis has become a major public health problem,
it is characterised by loss of bone mass and architecture
due to disturbance in bone remodelling. Most current
treatments retard bone loss but have no stimulating effect
on bone formation [1]. Osteocytes act as an orchestrator
for bone modelling, and secrete the glycoprotein sclerostin
which negatively regulates bone formation and is a poten-
tial novel drug target [2]. Due to difficulty of accessing and
studying osteocytes in vitro, an osteocyte-like MLO-Y4
cell line was developed. However, these cells only secrete
sclerostin in trace amounts [3]. The objective of this study
was to develop a novel biomimetic environment that
would stimulate MLO-Y4 to express the osteocyte specific
Sost gene.
Methods
Four different compositions were seeded with MLO-Y4
cells and accommodated in two different cultures (3D
scaffolds versus 2D films). After 5 days of culture, Sost
gene expression was analysed using Real-time PCR in all
groups and the data was normalised to a housekeeping
gene (18s).
Results
There was a robust statistically significant increase in
MLO-Y4 gene expression for Sost when cultured on a
Collagen-Hydroxyapatite (HA) substrate compared to a
Collagen-only substrate. Furthermore, the 3D dimen-
sionality enhanced gene expression across all different
compositions.
Conclusions
This study has demonstrated that scaffold composition
and dimensionality has a significant influence upon
regulation of MLO-Y4 gene expression. This also indi-
cates that Sost gene is regulated by both composition and
dimensionality. The ability to stimulate MLO-Y4 cell line
to express Sost sufficiently will offer a precious tool for
researchers to further study sclerostin secretion, identify
novel regulators of Sost gene expression and investigate
them to develop new therapeutic agents that may offer
advantage over the currently available treatments for
osteoporosis.
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